Our study reveals that OTULIN significantly mitigates neuropathic pain and neuroinflammation in trigeminal neuralgia by activating autophagy and inhibiting the NLR family pyrin domain containing 3 inflammasome, highlighting its potential as a therapeutic target. This evidence concerns the gene NLRP3 and trigeminal nerve disorder.